Global Antibody Drug Conjugates Contract Manufacturing Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2022 –2029 |
 Market Size (Base Year) |
USD 8.20 Billion |
 Market Size (Forecast Year) |
USD 12.35 Billion |
 CAGR |
% |
| Major Markets Players |
>全球抗体药物偶联物合同制造市场，按病症（骨髓瘤、淋巴瘤、乳腺癌、其他（尿路上皮癌）、连接体（可裂解连接体、不可裂解连接体）划分 – 行业趋势及 2029 年预测
抗体药物偶联物合同制造市场分析和规模
药物和抗体偶联物。ADC，也称为抗体-药物偶联物，是一类生物制药药物，旨在用于癌症治疗的靶向疗法。与化疗不同，ADC 旨在靶向和摧毁肿瘤细胞，同时保护健康细胞。
Data Bridge Market Research 分析，抗体药物偶联物合同制造市场在 2021 年为 82 亿美元，到 2029 年将飙升至 123.5 亿美元，预计在 2022 年至 2029 年的预测期内复合年增长率为 5.25%。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外，Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、管道分析、定价分析和监管框架。
抗体药物偶联物合同制造市场范围和细分
|
报告指标 |
细节 |
|
预测期 |
2022 至 2029 年 |
|
基准年 |
2021 |
|
历史岁月 |
2020（可定制为 2014 - 2019） |
|
定量单位 |
收入（单位：十亿美元）、销量（单位：台）、定价（美元） |
|
涵盖的领域 |
病症（骨髓瘤、淋巴瘤、乳腺癌、其他（尿路上皮癌）、连接子（可裂解连接子、不可裂解） |
|
覆盖国家 |
北美洲的美国、加拿大和墨西哥、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、巴西、阿根廷和南美洲其他地区 |
|
涵盖的市场参与者 |
三星生物制剂（韩国）、龙沙（瑞士）、Catalent Inc.（美国）、Siegfried Holding AG（瑞士）、Piramal Pharma Solutions（印度）、勃林格殷格翰国际有限公司（德国） |
|
市场机会 |
|
市场定义
增长最快的抗癌药物之一是抗体-药物偶联物 (ADC)。这种方法使用 mAb 通过化学接头连接到致命有效载荷上，该有效载荷针对癌细胞表面表达的靶抗原，从而限制全身暴露和毒性。ADC 是复杂的分子，需要特别考虑多种因素。
Antibody Drug Conjugates Contract Manufacturing Market Dynamics
Drivers
- Increase in demand of medicines
The market's growth is primarily driven by two factors: the increase in the need for medicines on a global scale and the advantage of lower total development costs with contract manufacturing.
- Rise in the geriatric population
The rising prevalence rates of lifestyle disorders like rising health-care spending, and the fast-growing diagnostic industry are driving the antibody drug conjugates contract manufacturing market expansion.
Opportunities
- Rise in cancer cases
The market is predicted to have considerable expansion over the course of the forecast period due to factors including rising need for biologic therapy, rising cancer prevalence, and outsourcing of operations and services to contract manufacturing companies.
Restraints/Challenges
The high cost of medicine development and distribution, on the other hand, will impede the market's rate of expansion. The market will be challenged by the shortage of trained personnel and inadequate healthcare infrastructure in developing nations.
This antibody drug conjugates contract manufacturing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the antibody drug conjugates contract manufacturing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Antibody Drug Conjugates Contract Manufacturing Market
The COVID-19 pandemic prompted the creation of COVID-19 vaccinations, antibody treatments, antiviral medications, and numerous other associated pharmaceutical items. Brazil, India, the United States, and several important European nations were severely affected by the epidemic, which increased demand for biopharmaceutical goods and, as a result, medicine production. To assure the quality and safety of their products, vaccines and biologics require specialised production and fill-finish techniques. This calls for highly developed analytical skills and flexible aseptic fill-finish technology. As a result, covid-19 had a favourable effect on the market.
Global Antibody Drug Conjugates Contract Manufacturing Market Scope
抗体药物偶联物合同制造市场根据条件、连接剂进行细分。这些细分市场之间的增长将帮助您分析行业中增长微弱的细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。
健康）状况
- 骨髓瘤
- 淋巴瘤
- 乳腺癌
- 其他（尿路上皮癌）
链接器
- 可裂解接头
- 不可切割接头
抗体药物偶联物合同制造市场区域分析/见解
对抗体药物偶联物合同制造市场进行了分析，并按上述国家、条件、链接器提供了市场规模洞察和趋势。
抗体药物偶联物合同制造市场报告涵盖的国家包括北美的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区（APAC）的其他地区、亚太地区（APAC）的沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲（MEA）的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。
由于老年人口的不断增长以及创新医疗技术的采用，北美在抗体药物偶联物合同制造市场中占据主导地位。
由于外包给合同制造组织的业务增加，预计亚太地区将在 2022 年至 2029 年的预测期内以最高的增长率增长。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
竞争格局和抗体药物偶联物合同制造市场份额分析
抗体药物偶联物合同制造市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对抗体药物偶联物合同制造市场的关注有关。
抗体药物偶联物合同制造市场的一些主要参与者包括：
- 三星生物制剂（韩国）
- 龙沙（瑞士）
- Catalent Inc.（美国）
- 齐格菲控股公司（瑞士）
- Piramal Pharma Solutions（印度）
- 勃林格殷格翰国际有限公司 (德国)
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
